NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2032220573

Registered date:17/01/2023

Performance verification test of a software medical device with artificial intelligence to detect signs of paroxysmal atrial fibrillation

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedparoxysmal atrial fibrillation
Date of first enrollment20/10/2021
Target sample size45
Countries of recruitment
Study typeInterventional
Intervention(s)Purpose of intervention: Diagnosis Type of intervention: Device,equipment Intervention: Artificial Intelligence Enabled EDC Analysis System

Outcome(s)

Primary OutcomeSensitivity and specificity for the results of sign detection
Secondary Outcome- AUC of ROC curve for sensitivity and specificity of diagnostic accuracy of detection of signs of paroxysmal atrial fibrillation in 25 patients in the paroxysmal atrial fibrillation group and 20 patients in the control group - Changes in the number of targeted blocks and in sensitivity and specificity for each case - Differences in sensitivity and specificity due to differences in block taking (10 consecutive blocks vs. 10 blocks independent in time) for each case - Type and number of adverse events - Type and number of Investigational device failure - Aggregation of vital signs and subjective symptoms

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 85age old
GenderBoth
Include criteriaParoxysmal atrial fibrillation group 1.Persons who have given written consent 2.Persons diagnosed as paroxysmal atrial fibrillation 3.Persons expected to have an atrial fibrillation attack more frequency than once a week Control group 1.Persons with confirmed sinus rhythm
Exclude criteriaParoxysmal atrial fibrillation group 1.Persons diagnosed with persistent or permanent atrial fibrillation 2.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure) Control group 1.Persons who have a history of diagnosis of paroxysmal atrial fibrillation, persistent atrial fibrillation, or permanent atrial fibrillation 2.Persons undergoing treatment(catheter ablation, open heart surgery, pacemaker implantation, percutaneous atrial septal defect closure)

Related Information

Contact

Public contact
Name Chieko Akiyama
Address 1-4-3 Mita, Minato-ku Tokyo Tokyo Japan 108-8329
Telephone +81-334518175
E-mail minamikawa@iuhw.ac.jp
Affiliation International University of Health and Welfare, Mita Hospital
Scientific contact
Name Yuichi Tamura
Address 1-4-3 Mita, Minato-ku Tokyo Tokyo Japan 108-8329
Telephone +81-334518175
E-mail u1@iuhw.ac.jp
Affiliation International University of Health and Welfare, Shool of Medicine